KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oscar Health (OSCR) Interest Expenses (2020 - 2025)

Historic Interest Expenses for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to -$1.1 million.

  • Oscar Health's Interest Expenses fell 11820.44% to -$1.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $17.6 million, marking a year-over-year decrease of 2584.06%. This contributed to the annual value of $17.6 million for FY2025, which is 2584.06% down from last year.
  • As of Q4 2025, Oscar Health's Interest Expenses stood at -$1.1 million, which was down 11820.44% from $6.9 million recorded in Q3 2025.
  • Over the past 5 years, Oscar Health's Interest Expenses peaked at $6.9 million during Q3 2025, and registered a low of -$1.1 million during Q4 2025.
  • Its 5-year average for Interest Expenses is $4.7 million, with a median of $6.0 million in 2024.
  • Its Interest Expenses has fluctuated over the past 5 years, first skyrocketed by 259342.11% in 2022, then plummeted by 11820.44% in 2025.
  • Over the past 5 years, Oscar Health's Interest Expenses (Quarter) stood at $397000.0 in 2021, then skyrocketed by 1445.34% to $6.1 million in 2022, then increased by 1.34% to $6.2 million in 2023, then decreased by 3.07% to $6.0 million in 2024, then tumbled by 118.2% to -$1.1 million in 2025.
  • Its Interest Expenses was -$1.1 million in Q4 2025, compared to $6.9 million in Q3 2025 and $5.8 million in Q2 2025.